FEDNAT HOLDING CO (FNHC)

US31431B1098 - Common Stock

0.2  -0.08 (-29.58%)

After market: 0.2003 +0 (+0.15%)

Fundamental Rating

1

Taking everything into account, FNHC scores 1 out of 10 in our fundamental rating. FNHC was compared to 140 industry peers in the Insurance industry. FNHC may be in some trouble as it scores bad on both profitability and health. FNHC does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

FNHC had negative earnings in the past year.
FNHC had a negative operating cash flow in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -10.62%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -48.09%
PM (TTM) -54.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

FNHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNHC has more shares outstanding
The debt/assets ratio for FNHC is higher compared to a year ago.

2.2 Solvency

FNHC has a Debt/Equity ratio of 8.41. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 8.41
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.72%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

FNHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.78%.
Looking at the last year, FNHC shows a very negative growth in Revenue. The Revenue has decreased by -36.27% in the last year.
Measured over the past years, FNHC shows a decrease in Revenue. The Revenue has been decreasing by -4.40% on average per year.
EPS 1Y (TTM)6.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-36.27%
Revenue growth 3Y-14.73%
Revenue growth 5Y-4.4%
Sales Q2Q%-19.86%

3.2 Future

Based on estimates for the next years, FNHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.92% on average per year.
Based on estimates for the next years, FNHC will show a small growth in Revenue. The Revenue will grow by 0.11% on average per year.
EPS Next Y71.85%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue Next Year23.58%
Revenue Next 2Y-0.57%
Revenue Next 3Y-0.45%
Revenue Next 5Y0.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

FNHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.32

4.3 Compensation for Growth

FNHC's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

No dividends for FNHC!.
Industry RankSector Rank
Dividend Yield N/A

FEDNAT HOLDING CO

NASDAQ:FNHC (11/4/2022, 8:00:00 PM)

After market: 0.2003 +0 (+0.15%)

0.2

-0.08 (-29.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)N/A N/A
Earnings (Next)11-22 2022-11-22/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners17.4%
Ins Owner Change0%
Market Cap3.50M
Analysts43.33
Price Target2.04 (920%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.9%
Min EPS beat(2)-19.83%
Max EPS beat(2)59.63%
EPS beat(4)1
Avg EPS beat(4)-91.41%
Min EPS beat(4)-239.72%
Max EPS beat(4)59.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.75%
Min Revenue beat(2)-37.95%
Max Revenue beat(2)-5.55%
Revenue beat(4)1
Avg Revenue beat(4)-8.49%
Min Revenue beat(4)-37.95%
Max Revenue beat(4)18.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA -0.32
EPS(TTM)-6.46
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-6.84
FCFYN/A
OCF(TTM)-6.74
OCFYN/A
SpS13.42
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -48.09%
PM (TTM) -54.3%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 8.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.81%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score1
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)136.84%
Cap/Depr(5y)128.06%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
EPS Next Y71.85%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue 1Y (TTM)-36.27%
Revenue growth 3Y-14.73%
Revenue growth 5Y-4.4%
Sales Q2Q%-19.86%
Revenue Next Year23.58%
Revenue Next 2Y-0.57%
Revenue Next 3Y-0.45%
Revenue Next 5Y0.11%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-297.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-285.93%
OCF growth 3YN/A
OCF growth 5YN/A